E.M. Bessell

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial

David Sebag‐Montefiore, Richard Stephens, R. Steele et al. · The Lancet · 2009 · 1.5K citations · Full text

Surgical Oncology, Health Sciences, Radiation Therapy +9

Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial

Philip Quirke, R. Steele, John R.T. Monson et al. · The Lancet · 2009 · 1K citations · Full text

Surgical Oncology, Gastrointestinal Oncology, Colorectal Surgery +10

European Phase II Study of Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) for Patients With Newly Diagnosed Mantle-Cell Lymphoma and Previously Treated Mantle-Cell Lymphoma, Immunocytoma, and Small B-Cell Lymphocytic Lymphoma

James M. Foran, A. Z. S. Rohatiner, David Cunningham et al. · Journal of Clinical Oncology · 2000 · 471 citations

Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life

M.H. Cullen, Lucinda Billingham, C.M. Woodroffe et al. · Journal of Clinical Oncology · 1999 · 448 citations

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Richard Adams, Angela Meade, Richard H. Wilson et al. · The Lancet Oncology · 2011 · 262 citations · Full text